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 Summary
  Many thousands of published papers, a lot of communications and daily practice show the 
outstanding role of proton spectroscopy (1H MRS) in neurooncology. Paradoxically, in several 
clinical centres (neurosurgery ones) we can observe the lack of full acceptance of the reliability of 
this method. Presumably, the reason for this attitude lies in non-uniform methodology and quite 
superficial treatment of spectroscopic results. At the beginning of this paper, we would like to 
stress that fortunately, there is a certain number of publications which order criteria of tumor's 
malignancy, its tissue characterisation and the degree of malignancy. In this paper we intend to 
point out the proper ways of improving reliability of 1H MRS in brain tumor diagnosis. Obviously, 
the quality of spectroscopic exams is influenced by methodology and manner of result interpretation 
(e.g. just simple visual inspection of MRS spectra is not sufficient for correct diagnosis).
  Currently, imaging diagnosis of brain tumors is based on many modalities (DTI, perfusion CT, MR, 
PET, SPECT) which are sufficiently effective in detection and differentiation of the lesions; in this 
context, we can say that 1H MRS spectroscopy constitutes the element of multimodal diagnostic 
approach for brain tumors.
  Nevertheless, the current papers concerning MR spectroscopy stress its significant role in making 
therapeutic decision, particularly as an alternative for surgery treatment and solution of the 
recurrence of tumor or/and extent of the tumor's spreading. Over 15 years of experience with 
1H MRS in diagnosis of brain tumors convinced us that these methods have very high diagnostic 
and decision-making value provided that it is properly applied and interpreted correctly. It is also 
important to choose the statistic methods that will show the best discriminators (markers) for 
particular pathologies. Authors' intention is to recommend the best ways to form the right diagnosis 
considering technological requirements, methodology and result interpretation.
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Technical Aspects
Magnetic resonance spectroscopy is based on the phenom-
enon called “chemical shift”. The resonance frequency of a 
certain atomic nucleus is to a small (but measurable) degree 
changed by the surrounding chemical bonds and, owing to 
that, the identification of particular molecules is possible.
The features of MRS spectrum, such as the number of reso-
nance lines, their position, the volume under each of them, 
depend on chemical structure of the examined compound. 
Analysis of spectrum can lead to identifying the compounds 
and their proportions in the studied sample. It enables 
studying simple and complex chemical compounds, as well 
as the metabolism of living cells in physiologic and patho-
logic states. The description of spectrum usually requires 
using a standard substance (internal substance). In the in 
vivo 1H MRS examinations the role is played by phospho-
creatinin.
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The most common spectroscopic techniques used in clinical 
practice are proton spectroscopy (1H MRS) and phosphor 
spectroscopy (31PMRS) [1–8] as those elements play the vital 
role in the assessment of metabolic turnover. The first one 
provides information about various metabolic disorders 
(acethylaspartate acid – nervous cells marker, creatinin 
– related to metabolic changes, choline – element of cell 
membranes, lactates – markers of anaerobic metabolism). 
The second one enables evaluation of energetic condition 
of the cells (phosphate compounds, mono- and biphosphate, 
phosphocreatinin, adenosine triphosphate ATP) and has 
application more in ischemic diagnosis than in oncology. 
Proton MR spectroscopy can be performed on most 1.5 T 
clinical MR equipment. There are two standard methods 
for data acquisition: single voxel spectroscopy (SVS) and 
multi-voxel spectroscopy (chemical shift imaging CSI)
Single Voxel Spectroscopy (SVS) – The Key Method 
Constantly
Single Voxel Spectroscopy enables registering the spectrum 
of selected volume, called the “volume of interest” (VOI) 
or voxel; this method is still most precise in locating the 
tissue which is examined. The SVS VOI localization meth-
ods include: ISIS (Image-Selected In-Vivo Spectroscopy), 
STEAM (Stimulated Echo Acquisition Mode), PRESS (Point-
Resolved Localized Spectroscopy); these methods has not 
changes till now.
Generally, the PRESS technique is recommended. As we 
know, it is a sequence of 3 pulses: 90°–180°–180°. A double 
spin-echo method enables good localization and strong sup-
pression of signals outside the selected voxel, while long 
duration of echo ensures a better visualization of metabo-
lites with long relaxation time.
Typical SVS spectroscopy protocols at 1.5 T:
1.  Metabolite ratios (clinical): repetition time (TR): 1–1.5s, 
the number of averages: 128, voxel size: 1.5×2×2 cm, 
acquisition time: 2–3 min;
2.  Semi-quantitative: repetition time (TR): 2s, the num-
ber of averages: 192, voxel size: 1×1×1.5 cm, acquisition 
time: 7 min;
3.  Quantitative: repetition time (TR): from 3s to 6s, the 
number of averages: 192, voxel size: 1×1×1.5 cm, acqui-
sition time 10 min (for TR=3s).
They represent a compromise between TR (this should ide-
ally be long to minimize T1 losses), number of averages or 
phase encodes (ideally large to achieve better SNR and/or 
spatial resolution) and acquisition time (which is short for 
the clinical sequences, and long for the more quantitative 
sequences).
Echo Time (TE) is dependent on examine metabolites. In 
many molecules, non-equivalent protons interact with each 
other in a phenomenon know as J-coupling. The result, in 
simple cases, is the splitting of peaks into doublets, triplets, 
etc. Furthermore, there is a time-dependence to J-coupling. 
In short TE spectra, the various components of a J-coupled 
lineshape are in phase, and add coherently. At longer TE val-
ues, the different components get out of phase. Some parts of 
a lineshape may be pointing up while other parts are point-
ing down. For example, in lactate is a doublet centred at 
1.33 ppm and quartet centred at 4.11 ppm. The doublet lines 
are in phase and pointed upward for short TE, out of phase 
with each other and other non-coupled peaks for TE=67 ms, 
in phase with each other but inverted with respect to the 
rest of spectrum at TE=135 ms, and pointed upward again 
at TE=270 ms. For more complicated J-coupled molecules 
one must examine them at short TE values before J-cou-
pling causes irreversible destruction of signal, much like 
a short T2. NAA, creatine, and choline all have uncoupled 
methyl group protons, so these molecules can be examined 
using either long or short TE spectra. Lactate is most easily 
detected at short TEs or at multiples of 135ms. Glutamine, 
glutamate, and myo-inositol are easily seen at short TEs. 
Unfortunately, lipids and macromolecules contribute a roll-
ing baseline to short spectra. Eddy currents and out-of-voxel 
artefact are worse at short TE, as is spectral overlap. For this 
reasons longer-TE spectra are easier to acquire and analyze. 
Thus, one often obtains two spectra from the same region.
Among SVS advantages are: high homogeneity of the field 
of the examined volume, easy selective water-suppression, 
high signal-noise ratio (S/N), and relatively short duration 
of the examination (around 4–8 minutes).
Multi-Voxel Spectroscopy – Still Valid But More Time-
Consuming And Not So Good Resolution
Multi-voxel spectroscopy or the CSI (Chemical Shift 
Imaging) is a technique, which visualizes the chemical 
shift in one measurement period and collects spectroscopic 
signals from multiple small voxels located within a large 
examined area. The registered signals form a map of spatial 
distribution of the metabolites.
Typical CSI spectroscopy protocols at 1.5 T:
1.  Semi-quantitative (clinical): TR: 2s, matrix: 16×16, 
FOV (field of view): 24 cm, voxel size: 1.5×1.5×1.5 cm, 
acquisition time: 8 min;
2.  Quantitative: TR: 3s, matrix: 24×24, FOV: 32 cm, voxel 
size: 1.3×1.3×1.5 cm, acquisition time: 29 min;
They represent a compromise between a quality of imaging 
and acquisition time.
The major disadvantage is that the shape of individual vox-
els is less well defined than in single voxel techniques, and 
the necessity of long echo-durations limits the amount of 
received data to 3 bands of metabolites. CSI is also more 
sensitive to heterogeneity of the magnetic field and to fat 
tissue-derived artefacts [9]. Long time necessary for acqui-
sition of the CSI data limits the use of this method in clini-
cal practice.
Preprocessing Techniques – Where Trouble May Begin
Because of the fact that the FID signal contains a lot of 
noises, unwanted signals and deformations connected with 
acquisition, application of various corrective techniques is 
inevitable.
The first stage of pre-processing is conducted in time domain 
(before the Fourier transformation). It includes: offset cor-
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rection, eddy current correction, zero filling and apodiza-
tion (multiplying the signal with appropriate S/N corrective 
functions). The next stage of processing the resonance spec-
trum, after the Fourier transformation (in frequency domain 
- FD), is based on the phase and baseline correction, and on 
calculating the area below the resonance bands of certain 
substances. In medical applications such procedures are 
usually carried out automatically with the use of software 
supplied by the tomography producer. This is the oldest, but 
still the fastest and straightforward method to quantify the 
spectrum lines. Most importantly, it is line-shape indepen-
dent. However, this method is prone to many mistakes and 
its use is limited to well-resolved peaks with good S/N ratio 
on a flat baseline. Accurate quantification of the in vivo 
spectra requires mathematical fit of the observed spectrum 
in order to disentangle the overlapping lines and to reliably 
estimate their area. Proper phase and baseline correction is 
the preliminary condition for correctness of this analysis. 
An introduction of the common processing methods in in 
vivo MR spectra is given in a few references [10].
Calculation of molar concentrations of the substances on 
the basis of integrals of corresponding resonance lines 
requires calibration. In view of the problems with reliable 
calculations of molar concentrations, the quantitative MRS 
results are often presented as intensity quotients of reso-
nance signals of particular metabolites (Metabolite Ratios, 
MR). Nevertheless, the MR must be interpreted with cau-
tion as, despite the fact that the metabolites proportion is 
enclosed within certain range, it does not mean that partic-
ular metabolites concentration has changed [11]. One of the 
programs enabling calculation of total metabolites concen-
tration is LCModel (Linear Combination of Model spectra). 
It matches linear combination of signals from single metab-
olites with spectrum of compounds measured independent-
ly. LCModel is especially useful for short TE (time of echo) 
and high concentration metabolites – myoinositol, gluta-
mine. The disadvantages include difficulties with accessi-
bility to the source code (the reason being commerciality of 
the program) and time-consuming manual adjustment.
Recently, more attention has been paid to time-domain 
quantification methods [12–14]. The visual interpretation 
of the measured MRS signals and the fitting results are best 
done in the frequency domain.
There exist a huge amount of software dedicated to MRS. 
We only mention a few of them: jMRUI quatitation pack-
age (quantitation methods: VARPRO, AMARES, QUEST), 
AQSES-GUI package, education MATLAB NMR data pro-
cessing package (NMRLAB).
Statistic Methods Supporting Diagnosis – Crucial 
Impact On Diagnostic Success
Various methods have been suggested for classification 
of spectra into groups used for diagnosis and prognosis. 
Classification is often achieved using logistic regression 
(LR), linear and quadratic discriminates (LDA, QDA) and 
Fisher criteria, the K-nearest neighbour classifier (KNN) or 
the Parzen density estimator, classification and regression 
tree (CART), random forest (RF), genetic algorithm, artificial 
neural networks (ANN) and support vector machines (SVM).
Linear discriminant analysis (LDA) is a technique that has 
been widely used in spectroscopy for pattern recognition 
and has obtained good results for many applications includ-
ing brain tumor classification. SVS have recently gained 
prominence in the field of machine learning and pattern 
classification [15]. The important advantage of SVM is that 
it offers a possibility to train generalizable, nonlinear clas-
sifiers in high dimensional spaces using a small training set.
Innovations In MR Spectroscopy
More and more efforts are being put into developing 
fast spectroscopic imaging techniques, such as Turbo 
Spectroscopic Imaging (TSI), echoplanar magnetic reso-
nance spectroscopic imaging (EP-MRSI), spiral MRSI, par-
allel spectroscopic imaging using SENSE. Further research 
effort will thus aim at investigating the potential of fast, 
highly resolved MRSI at high field, as well as at achieving 
whole-brain coverage by 3D acquisition.
Functional Spectroscopy (fMRS)
The development of fast imaging techniques in spectros-
copy enabled observation of dynamic metabolic processes 
in brain. The fMRS scanning requires the same equipment 
as fMRI but uses a different kind of software made for 
recording various levels of chemical substances. The main 
difference between the aforementioned techniques is that 
fMRS measures the changes of metabolites, while the fMRI 
- blood oxygenation (BOLD). One of the substances that can 
be measured by fMRS is the lactate, considered as deter-
minant of anaerobic metabolism. The idea of observing 
the lactate in fMRS is based on the following mechanism: 
increased electric activity of region of the brain (caused 
by a certain task) uses up the energy and that leads to the 
growth of nutrients consumption (i.a. oxygen, glucose) and 
increase of blood flow. Metabolism is increased and so is 
the lactate (which is a by-product). The disadvantage of 
this method is a relatively long measuring time and actu-
ally small lactate signal, which still makes the optimization 
of spatial resolution a challenge, if the SNR is to be main-
tained at the a sufficient level [15].
Multinuclear Spectroscopy – Not Only Proton 
Spectrocopy
The MR spectroscopy uses spectra of various elements. Apart 
from the aforementioned hydrogen spectroscopy (1H MRS) 
and phosphoric spectroscopy (31PMRS), the carbon (13C 
MRS) and fluoric (19FMRS) spectroscopy are also used [16]. 
Compared to the 1H other nuclei, especially 31P and 13C, are 
less sensitive. Nuclid spectra with appropriate S/N require 
a much longer measuring time. The carbon, phosphor and 
fluorine spectra need additional device/tool for detection 
and transmission, which operates on resonance frequency of 
nuclei of our interest. A typical spectrum of the aforemen-
tioned nuclids is complex; it has a wide band of chemical shift 
and contains signals, which are split into multiplets. [17].
Hyperpolarized 13C
The main reason for general low sensitivity of NMR tech-
niques is low polarization of nuclei in thermal balance; 
Review Article
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even in the high fields only one in 105 of nuclei contributes 
to the measured signal. However, it is possible to improve 
polarization of selected nuclei by a factor of 100000 or 
more. The enhancement of polarization can be obtained by 
increasing the magnetic field. Another idea to improve the 
polarization is to create artificial non-equilibrium arrange-
ment of the nuclei. The state of hyperpolarization, in which 
the difference in population of spins of high or low energy 
increases by a few rows compared to the balance state does 
not depend on the outer magnetic field. Hyperpolarization 
concerns mainly the organic substances containing 13C or 
the following nuclei: 3He, 129Xe and 15N. There are two 
methods of hyperpolarization: DNP (dynamic nuclear polar-
ization) and PHIP (para-hydrogen-induced polarization). 
Hyperpolarization enlarges signal amplitude what results 
in reduction of scanning time to a few seconds. [18].
Clinical Aspects
Considerable amount of papers concerning the value of 
1H MRS in brain tumors was published in many countries 
around the world during the last 10 years, unfortunately 
less than 100 contain broad clinical material, sufficient sta-
tistics and current point of view on tumors in 1H MRS. An 
excellent reference material concerning this issue could be 
accessed in the paper published by W. Hollingworth et al 
[19]
Owing to literature data and our own experience of more 
than 10 years,we have made an effort to categorize pub-
lications according to the several following main clinical 
subgroups: metastasis versus high-grade astrocytoma, high 
vs low-grade astrocytoma, tumor extent before treatment, 
neoplastic vs nonneoplastic lesions, recurrent or residual 
tumor versus treatment-related change; the aforemen-
tioned topics allow us to list the most important problems 
concerning 1H MRS in the diagnostics of brain tumors. The 
following topics could establish the formal applications for 
1H MRS in brain tumors diagnosis:
1.  Diagnosis of brain tumors and selection from nontumoral 
pathology, tumors classification and grading.
2.  Detection of tumor recurrence vs radiation necrosis, 
differentiate delayed radiation necrosis from recurrent 
tumor.
3.  Evaluation of the extent of tumors infiltration (uncertain 
zone).
In terms of point 1 one is able to state, rather rough-
ly, that commonly analyzed types of tumor ratios and/or 
metabolites concentrations, are more or less different 
from control group. These ratios of particular metabo-
lites to Cr are as follows: Lip/Cr, Lac/Cr, Ala/Cr NAA/Cr, 
Cho/Cr, mI/Cr,Glx/Cr and ratios of those metabolites to 
Figure 1.  12-year-old girl with AA scheduled for surgery. 1H MRS 
(long TE-135 ms) reveals extremely high level/ratio of Cho, 
presence of Lac, Lip and low level of NAA.
Figure 2.  26-year-old man with pontine glioma (AA, confi rmed by 
biopsy) after many courses of radiotherapy. 1H MRS, SVS 
and CSI show elevation of Cho and Lac; owning to colored 
mapping of metabolites distribution obtained from CSI, 
extension of Cho elevation areas is observed.
A
B
C
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unsuppressed water. High-grade gliomas, mostly ana-
plastic astrocytoma (III) and glioblastoma multiforme (IV) 
tended to have higher Cho/Cr, Cho/NAA, Lac/Cr and Lip/Cr 
and low/or extremely low/ NAA/Cr and mI/Cr; these tumors 
are well differentiated from the rest of astrocytic tumors 
mainly by the presence of a broad resonance centred at 
0.9 and 1.3 ppm attributable to lipids (Lip) and presence of 
increased concentration of Lac and Cho (Figures 1,2).
Increased Lip concentration is significantly recognized in 
high grade astrocytoma, can be treated however as a mark-
er of AA and GBM; this would agree with the findings that 
high grade gliomas contain mobile lipids,the amounts of 
which correlate with the extent of cell necrosis on micros-
copy [20].
Studies using 1H MRS indicate a similar correlation 
between metabolic profile in vivo and the histological grade 
of gliomas and indicate that also lactates (Lac) are more 
likely to be present in high-grade tumors not only of glial 
origin, especially metastases [1–3,19] (Figure 3).
One of the most important spectroscopic marker of tumor's 
growth is Cho, the presence of which in low and high 
grade glioma is acknowledged by many authors [1,20,22] 
(Figure 4.) However, an enthusiastic approach to the value 
of Cho as a marker of tumor's malignancy is lowered by 
the fact that Cho may result from the degradation of cell 
membrane but also because of the proliferation of cells. 
[2,19,20].
Figure 3.  59-year-old man with left side hemiparesis and two 
seizures, reported a few month ago; surgery and 
histopathology confi rmed metastatic tumor (lung 
carcinoma). (A) MRI (FLAIR) revealed oval tumor in the 
right hemisphere surrounded by edema zone; (B) 1H MRS 
is characterized by expression of Lac and Lip, elevation of 
Cho/Cr ratio, also one can observe relatively high level of 
NAA (and ratio to Cr). (C,D) Preoperative DTI (FA images and 
Tractography) demonstrated displacement and compression 
of motor fi ber pyramidal tracts, without features of 
infi ltration.
A
B
C
D
Review Article
54
© Pol J Radiol, 2009; 74(1): 50-58
In majority of 1H MRs studies based on abundant material 
deriving our own and from the cooperating centers (over 
250 pts in 2004–2007), proton spectroscopy was very accu-
rate in differentiating high and low grade gliomas achieving 
sensitivity no less than 95% and specificity 92%. Results dif-
ferences among all centers were not significant; our experi-
ence indicates that diagnostic accuracy diminished in the 
differentiation grade III and grade IV tumors. Knowledge of 
tumor grading influences therapeutic decisions and should 
be constituted also by non-invasive diagnostic methods like 
1H MRS. The ratios of maximum Cho/NAA,Cho/Cr and mini-
mum NAA/Cr are highly correlated with tumor grade except 
for the difference between GBM and AA
No Lac or Lip peak was detected in the solid part of low-
grade tumors found only in high-grade gliomas, which 
suggests that Lip and Lac peaks may have discriminatory 
power.
Because the presence of mobile lipids in high grade astro-
cytomas correlates with necrosis and the latter with prog-
nosis, it is strongly possible that mobile lipids in anaplas-
tic glioma can act as a marker for tumors likely to exhibit 
more aggressive behaviour [4,19,21]. Although large 
amounts of lipids appear to be specific for anaplastic glio-
mas or GBM,however their absence does not exclude either 
of them.
One of the true markers of low grade astrocytoma (LGA) 
is myoinositol (mI) which indicates proliferation of glial 
cells and also Cho (Figures 4,5); elevated mI is observed 
exclusively in this type of tumor. However, in malignant 
glioma mI decreases due to prevalence of rapid growth and 
necrosis [20]; Cho has usually slightly lower concentration 
D
Figure 4.  35-year-old women with tectal glioma (astrocytoma), 
confi rmed by biopsy, revealed in MRI (see sagittal plane). 
1H MRS showed high mI/Cr and Cho/Cr ratio from tectal 
region (suspected of tumor) suggestive of low grade 
glioma.
A C
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in LGA, which we can explain as a result of lower prolif-
eration power and slower cell's destruction in comparison 
with malignant tumors.
Apart from the fact that 1H MRS is moving forward 
we are practically able to differentiate several intran-
cranial tumors, limited to four types: low and high 
glioma,meningioma and metastases. For example, in menin-
gioma (MEN) alanine (Ala) is the most characteristic peak 
(1.4–1.5 ppm); this resonance shows high levels of statisti-
cal significance for all of Ala compartments.
Other findings characteristic of MEN are:
1. Increase of Cho with respect to LGA,GBM and MET.
2. Increase of Glx in reference to LGA and AA.
3. The lack of Lip 1.3 with respect to MET or GBM.
The strongest discriminative performance between intra-
cranial tumors (Lip,Lac, Ala, NAA, Cho, mI) can be per-
formed in many algorithms, which are widely discussed in 
chapter entitled “Technical Consideration”.
Development of in vivo 1H MRS for noninvasively predict-
ing and /or detecting tumor response to therapy at an early 
stage requires identification of metabolites concentration of 
which correlates with tumor response to therapy,or those 
which indicates the failure of treatment.
In the most studies the ratios of resonance signals assigned 
to the major 1H MRS – visible metabolites: NAA, Cho, Cr, 
mI, Lac and Li (methylene group) were evaluated before, 
during and after post-surgical fractionated radiotherapy 
(usually 60 and <40 Gy respectively), which was performed 
in brain's region close to and more distant from the tumor 
bed; most of researchers reported that four metabolites 
such as Lac,NAA,Cho and mI can be treated as a markers 
of local irradiation injury, while diminishing of Lac con-
centration indicates radiation response; mechanism leading 
to decreasing of lactate concentration is probably connect-
ed with increased blood flow and /or decreased glycolysis 
activity of tumor's tissue. Choline is the second metabolite 
which can be a marker for failure of radiotherapy; there are 
findings which suggest that increasing Cho/Cr and Cho/NAA 
ratio and increasing of Lac concentration indicates radio-
therapy failure and early tumor recurrence [22–25].
1H MRS is valuable method in distinguishing recurrent 
tumor from treatment related changes (Figures 6,7) In most 
B
A
Figure 5.  45-year-old man suff ered from fi rst-time episode of 
epilepsy. 1H MRS obtained from the area of tumor reveals 
spectrum typical for low grade glioma: elevation of Cho and 
mI, slightly decreased NAA level. Histopathology confi rmed 
the presence of oligodendroglioma.
B
A
Figure 6.  69-year-old man after surgical removal of GBM in left 
frontal lobe. The surgery was performed in 2005 and 
recently we have observed increased frequency of seizures.
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56
© Pol J Radiol, 2009; 74(1): 50-58
patients from those group increased choline peak and ratio 
to Cr has been noticed; following several studies quoted by 
Hollingworth [19] an increased Cho peak was higher than 
80% sensitive and more than 85% specific in distinguishing 
tumor from radiation – induced necrosis; However, many 
authors note that PET has much higher sensitivity (95%) 
and specificity (100%) than 1H MRS in this matter. It can be 
assumed that fusion of 1H MRS and CT or MR perfusion are 
able to improve accuracy in this crucial problem.
MRI reveals post-surgical cavity in the left frontal lobe and 
extensive area of brain tissue destroyed after radiothera-
py (leucomalacia); no mass effect and no edema. 1H MRS: 
spectrum from the VOI located in this area is typical for the 
proliferation of the tumor showing elevation of Cho, Lac 
and Lip.
The determination of tumor boundaries, especially in high-
grade glioma is critically important for the proper planning 
of treatment. However, the standard diagnostic imaging 
methods do not enable precise outlining of the extension of 
tumor cell infiltration into the surrounding tissue (uncer-
tain zone), which appears normal on standard diagnostic 
MR images (Figures 8,9). Many papers [23–25] reported that 
1H MRS demonstration of metabolic changes in peritumoral 
zone can modify treatment for cerebral glioma (pre-surgical 
planning, extension of post-surgical radiotherapy) and allows 
to predict risk of early recurrence, because the peritumoral 
BA
Figure 7.  40-year-old man underwent surgery for anaplactic glioma in 2006. Treated with intensive radiotherapy he hasn't shown signs of 
recurrence till now. 1H MRS obtained from right frontal lobe revealed spectrum from. VOI located in adjacent to resection area performed 
fi ve month after MRI examination which showed, without doubt, recurrence of tumor; Spectrum from the VOI located in this area is typical 
for the proliferation of the tumor showing elevation of Cho, Lac and Lip, depressed of NAA and Cr due to radiotherapy (leucomacia).
Figure 8.  32-year-old woman underwent surgery 
due to temporal brain tumor. Low grade 
glioma was diagnosed. 1H MRS reveals 
spectra from solid part of tumor, from 
border zone and tissue distant from the 
tumor. There are no signs of recurrence 
after more than fi ve years since the 
surgery.
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zone is most often the starting point for postoperative recur-
rence of glioma. The clinical importance of the peritumoral 
zone for future neuropathologic changes has been known for 
many years; it is assumed that malignant gliomas are not 
strictly focal lesions, but are also characterized by the cere-
bral spreading of malignant cells along the axons, perivascu-
lar spaces and/or through the subarachnoid space.
Connclusions
Above discussed aspects, considerations and technical pos-
sibilities, as well as methodological requirements, guide-
lines and clinical applications of proton spectroscopy 
strengthens our belief in the power of this method used in 
neurooncological diagnosis.
Figure 9.  55 year old man with GBM, confi rmed 
during the surgery. 1H MRS obtained 
inside the tumor and adjacent tissue 
indicate tumor infi ltration besides 
apparent tumor. Survival period since 
surgery till death was 7 months.
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